pulmonary arterial hypertension
MHRA authorises Biogen’s higher-dose Spinraza for SMA treatment
SMA is a rare genetic neuromuscular condition affecting around 1,600 people in the UK
UK clinical trial regs are changing — here’s what’s happening
Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.
Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment
Quotient’s somatic genomics platform technology will be used to develop the treatment
MHRA approves Leqselvi for severe alopecia areata
Around 30% of patients saw 80% more scalp hair after 24 weeks of treatment
Moderna and Merck announce data from melanoma combination therapy study
Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths
Novo Nordisk’s Wegovy higher dose injection approved by UK MHRA for obesity
Obesity affects approximately 15 million people in the UK
GSK’s Nucala approved by MHRA for uncontrolled COPD
Symptoms of COPD include breathlessness, persistent cough and frequent chest infections
Merck announces agreement with US government to reduce prices of prescription medication
The pharma company will invest more than $70bn in the US to boost production and innovation
Merck agrees deal with Cidara Therapeutics worth almost $9.2bn
Cidara’s long-acting viral flu drug showed significant protection in phase 2 results
Biogen and Eisai receive MHRA approval for updated dosing of early Alzheimer’s treatment
The MHRA approval for IV dosing comes following positive results from the global phase 3 trial
Merck ends development agreement with Dr Falk Pharma for monoclonal antibody
Merck will take full control of developing MK-8690, an investigational monoclonal antibody candidate
Merck and Blackstone agree on funding for cancer protein antibody
The funding will support late-stage clinical development of the investigational antibody-drug conjugate